NEW YORK, Nov. 09, 2022, a global leader in genomics and precision medicine, are pleased to announce a commercial partnership to provide patients with a wide range of clinical genomic tests, including
NEW YORK, Nov. 07, 2022, a global leader in genomics and precision medicine, announced that the Company will be participating in The Canaccord Genuity MedTech Diagnostics and Digital Health and Services
A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 31st October – 4th November .
- Leaders in biotech and genomics to launch more personalised genomic solutions to more than 10,000 people across the Baltics and Mediterranean regions -L'AQUILA, Italy, Nov. 01, 2022, a global leader